Alira Health Starts a New Collaboration with Mark Inigo Jones on Parallel Trade Management

News
Published on:
August 29, 2020

BOSTON, USA – Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, is pleased to announce a new collaboration with Mark Inigo Jones, an industry leader in European parallel trade of pharmaceutical products. Mark brings his extensive knowledge, implementation, and operational experience in effective strategies for parallel trade management initiatives to the firm’s Market Access practice and Parallel Trade practice. The firm’s clients, which includes over 50% of the top 100 pharmaceutical companies, will benefit from this enhanced service offering, which aligns closely with the firm’s market access, pricing, and reimbursement services.

Shaped on best practices developed through his years at Novartis, Mark’s collaboration with Alira Health rounds out a new team focused on supporting clients in increasing profitability and protecting brand reputation through dedicated initiatives for effective parallel trade management.  Using an innovative, data-driven approach, the Alira Health team has extensive operational experience and a record of achievement in supporting clients as they develop and implement successful EU-compliant distribution strategies. A cornerstone of Alira Health’s Parallel Trade practice is to help companies develop their internal capabilities in effective parallel trade corporate governance.

Previously, Mark was the Head of European Trade at Novartis, where he developed and implemented the corporate strategy that lead to the largest reductions in parallel trade of any pharmaceutical peer company. During his time at Novartis, Mark managed portfolios for Alcon and GSK Oncology, where he achieved an increase of the profitability of the brands up to 30 % within 12 months of taking responsibility for their distribution.

Mark holds a variety of master’s degrees in related fields, including EU Competition Law from Kings College London, Health Economics from the London School of Economics, and Finance from The London School of Business. He has also lectured on Parallel Trade at the European Center of Pharmaceutical Medicine course at the University of Basel.

For more information about Alira Health’s Parallel Trade services

Click here

Related news

MedTech
News July 22, 2021
Alira Health Welcomes Fredrik Nyberg as Partner and Regional Head
We are pleased to announce that Fredrik Nyberg has joined Alira Health as Partner and Regional Head
MedTech
Events July 15, 2021
Event: Cardio Wearables 2021 Conference
Join Piergiulio Lauriano for an exclusive discussion on Cardio Wearables Investments and M&A Trends during the conference.
Market Access
Events July 11, 2021
Event: MTAA Value Based Procurement Webinar & Conference
Sign up for Alira Health's very own, Richard Charter's exclusive webinar on value-based procurement.
MedTech Pharma
Events June 30, 2021
Event: Bio Asia-Taiwan
Join Daniela Sica, Vice President, Business Development, Pharma & Biotech, and Shu-Ling Cheng, Partner, at Biotechnology Innovation Organization's Bio-Asia Taiwan July 21-25, 2021.
MedTech
Publications June 2, 2021
Infographic: U.S. Go-to- Market Strategy Design for Wearable Technology in Healthcare
When our client, a European healthcare-based startup developing wrist wearables wanted to expand to the U.S., the Alira Health team helped develop a go-to-market strategy for this new segment.
MedTech
Publications May 14, 2021
Pocket Guide To MedTech’s Market Outlook In 2021
In this article Carlo unveils findings and summaries from The 2021 MedTech Contract Manufacturing Report, recently published by Alira Health in collaboration with Life Science Intelligence(...)
MedTech
Publications May 7, 2021
Robotic Surgery Report Pre-download
Want to learn more about key topics and trends across robotic surgery and commercial considerations? Be the first to have access to our upcoming report on Robotics, written by Alira(...)

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.